Key result
caFFR-discordant revascularisation in NSTE-ACS shows similar overall MACE but ~8-fold higher MI risk.
Why the study?
While the diagnostic accuracy of computational pressure-flow dynamics-derived fractional flow reserve (caFFR) is well-established, the clinical impact of adhering to caFFR-guided revascularisation strategies in patients with NSTE-ACS remained to be fully elucidated.
Does a caFFR-concordant revascularisation strategy reduce Major Adverse Cardiovascular Events (MACE) compared to discordant revascularisation strategies in patients with NSTE-ACS?
Cohort (n=283)
Does a caFFR-concordant revascularisation strategy reduce Major Adverse Cardiovascular Events (MACE) compared to discordant revascularisation strategies in patients with NSTE-ACS?
In NSTE-ACS patients, a revascularisation strategy discordant with caFFR—particularly undertreating physiologically significant lesions—is associated with a significantly higher risk of myocardial infarction despite no statistically significant difference in overall composite MACE.
Background Computational pressure-flow dynamics-derived fractional flow reserve (caFFR) enables FFR determination from angiography alone, without invasive pressure wire or hyperaemic stimulus. While its diagnostic accuracy is well-established, the clinical impact of adhering to caFFR-guided revascularisation strategies in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) remains to be fully elucidated. Purpose To determine whether caFFR-concordant revascularisation improves cardiovascular outcomes compared with discordant strategies in NSTE-ACS patients. Methods This retrospective cohort study analysed 283 NSTE-ACS patients (mean age 67.4±12.7 years; 65.7% male) with interpretable three-vessel caFFR who underwent revascularisation between 2014 and 2017. Patients underwent revascularisation at the discretion of the proceduralist according to the angiographic and clinical data available at the time. Concordant strategy was defined as PCI of all ischaemic vessels (caFFR ≤0.80) with deferral of non-ischaemic vessels (caFFR >0.80); all other patterns constituted discordant strategies. To minimise indication bias, inverse probability of treatment weighting was used to balance baseline characteristics (standardised mean difference <0.10). The primary endpoint was Major Adverse Cardiovascular Events (MACE; composite of cardiovascular mortality, myocardial infarction, and ischaemia-driven revascularisation) over median 4.3-year follow-up (IQR 4.0–4.6). Weighted Cox regression and Kaplan-Meier analyses assessed time-to-event outcomes. Results After IPTW adjustment, 157 patients (55.5%) received concordant and 126 (44.5%) discordant revascularisation. Among discordant cases, 72 (57.1%) were overtreated and 54 (42.9%) undertreated. While composite MACE rates and risk were similar (concordant 14.6% vs. discordant 19.0%; weighted HR 1.30, 95%CI 0.69—2.44, p=0.413), discordant strategy significantly increased the incidence rate and risk of myocardial infarction (10.4% vs. 1.2%; weighted HR 8.13, 95%CI 1.73–38.30, p=0.008). Sub-analysis of the discordant group revealed that this risk was predominantly driven by a significantly higher risk of MI for undertreatment compared to overtreatment (weighted HR 5.64; 95% CI 1.12–28.34; p=0.036). There was also a trend towards increased MACE in the undertreated group (weighted HR 2.32; 95% CI 0.97–5.51; p=0.058). Conclusion In patients with NSTE-ACS, a revascularisation strategy discordant with caFFR—particularly the undertreatment of physiologically significant lesions—is associated with a significantly higher risk of myocardial infarction. These findings suggest that integrating caFFR into the clinical decision-making process for NSTE-ACS may improve prognostic outcomes by ensuring haemodynamically significant stenoses are appropriately addressed.
No takes yet. Share an insight, caveat, or question.
Sze et al. (2026) conducted a cohort in Non-ST-elevation acute coronary syndrome (NSTE-ACS) (n=283). caFFR-discordant revascularisation strategy vs. caFFR-concordant revascularisation strategy (PCI of all ischaemic vessels with caFFR ≤0.80 and deferral of non-ischaemic vessels with caFFR >0.80) was evaluated on Major Adverse Cardiovascular Events (MACE; composite of cardiovascular mortality, myocardial infarction, and ischaemia-driven revascularisation) (weighted HR 1.30, 95% CI 0.69-2.44, p=0.413). caFFR-discordant vs concordant revascularisation in NSTE-ACS had similar MACE (19.0% vs 14.6%; HR 1.30, p=0.413) but higher MI risk (10.4% vs 1.2%; HR 8.13, p=0.008).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Acute coronary syndromeMore from European Heart Journal